Antifungal susceptibility testing using the E test: Comparison with the broth macrodilution technique

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 2, 1996, Pages 265-273

  Chen, Sharon C A ^a   O'Donnell, Maryann L ^a   Gordon, Suzannah ^a   Gilbert, Gwendolyn L ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE;

ARTICLE; CANDIDA; CRYPTOCOCCUS NEOFORMANS; DILUTION; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; YEAST;

ANTIFUNGAL AGENTS; CANDIDA; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIA; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICROBIAL SENSITIVITY TESTS; REPRODUCIBILITY OF RESULTS;

EID: 0030012303     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.2.265     Document Type: Article

References (18)

1. Anaissie, E. J., Bodey, G. P. & Rinaldi, M. G. (1989). Emerging fungal pathogens. European Journal of Clinical Microbiology and Infectious Diseases 8, 323-30.
2. Anonymous. (1993). E Test technical guide no. 4: antifungal susceptibility testing of yeasts. AB BIODISK, Solna, Sweden.
3. Anonymous. (1994). E Test technical guide no. 4b: antifungal susceptibility testing of yeasts. AB BIODISK, Solna, Sweden.
4. Beck-Sagué, C. M. & Jarvis, W. R. and the National Nosocomial Infectious Surveillance System (1993). Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. Journal of Infectious Diseases 167, 1247-51.
5. Bolmström, A. & Odds, F. (1994). Comparison of antifungal susceptibility testing with E test and other methods for clinically documented isolates. In Program and Abstracts of the Twelth Congress of the International Society of Human and Animal Mycology, Adelaide. South Australia, 1994. Abstract P4.2, p.D.42.
6. Cameron, M. L., Schell, W. A., Bruch, S., Bartlett, J. A., Waskin, H. A. & Perfect, J. R. (1993). Correlation of in-vitro fluconazole resistance to Candida isolates in relation to therapy and symptoms in individuals seropositive for human immunodeficiency virus type I. Antimicrobial Agent and Chemotherapy 37, 2449-53.
7. Colombo, A. L., Barchiesi, F., McGough, D. A., Rinaldi, M. G. (1995). Comparison of E test and National Committee for Clinical Laboratory Standards broth macrodilution method for azole susceptibility testing. Journal of Clinical Microbiology 33, 535-40.
8. Espinel-Ingroff, A., Bolmström, A. & Jones, R. Collaborative evaluation of E test for antifungal susceptibility testing with 5 antifungal agents against pathogenic yeasts. In Abstracts of the Ninety-Fourth General Meeting of the American Society for Microbiology, Las Vegas, 1994. Abstract F-112, p. 608. American Society for Microbiology, Washington, DC.
9. Fromtling, R. A., Galgiani, J. N., Pfaller, M. A., Espinel-Ingnoff, A., Bartizal, K. F., Bartlett, M. S. et al. (1993). Multicentre evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrobial Agents and Chemotherapy 37, 39-45.
10. National Committee for Clinical Laboratory Standards. (1992). Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts. Proposed Standard Document M27-P. NCCLS, Villanova, PA.
11. Pfaller, M. A. & Barry, A. L. (1994). Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. Journal of Clinical Microbiology 32, 1992-96.
12. Pfaller, M. A., Grant, C., Morthland, G. V. & Rhine-Chalberg, J. (1994). Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. Journal of Clinical Microbiology 32, 506-9
13. Pfaller, M. A., Rinaldi, M. G., Galgiani, J. N., Bartlett, M. S., Body, B. A., Espinel-Ingnoff, A. et al. (1990). Collaborative investigations of variables in susceptibility testing of yeasts. Antimicrobial Agents and Chemotherapy 34, 1648-54.
14. Rex, J. H., Pfaller, M. A., Rinaldi, M. G., Polak, A. & Galgiani, J. N. (1993). Antifungal susceptibility testing. Clinical Microbiological Reviews 6, 367-81.
15. Sewell, D., Pfaller, M. A. & Barry, A. L (1994). Comparison of broth macrodilution, broth microdilution and E test antifungal susceptibility tests for fluconazole. Journal of Clinical Microbiology 32, 2099-102.
16. Smith, K. J., Warnock, D. W., Kennedy, C. T., Johnson, E. M., Hopwood, V., Van Custem, J. et al. (1986). Azole resistance in Candida albicans. Journal of Medical and Veterinary Mycology 24, 133-44.
17. Warren, N. G. & Shadomy, H. J. (1991). Yeasts of medical importance. In Manual of Clinical Microbiology, 5th edn (Balows, A. Hausler, W. J., Hermann, K. L., Isenberg, H. D. & Shadomy, H. J., Eds), pp. 617-629. American Society for Microbiology, Washington, DC.
18. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R. & Karp, J. E. & Saral, R. (1991). Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine 325, 1274-7.